Pertussis - A Comprehensive Review of Etiology, Diagnosis, Treatment and Prevention
DOI:
https://doi.org/10.12775/QS.2025.43.62347Keywords
pertussis, whooping cough, COVID-19, infection, macrolides, vaccines, prophylaxis, antibodiesAbstract
Introduction and Aim:
Whooping cough, caused by Bordetella pertussis, remains a global health challenge despite widespread vaccination. This review summarizes current data on its epidemiology, pathogenesis, and clinical presentation across age groups.
Materials and Methods:
The review analyzes scientific literature, reports, and guidelines up to June 2025, sourced from PubMed. Search terms included “whooping cough” combined with “epidemiology,” “COVID-19,” “vaccinations,” and “macrolides.” Data underwent qualitative and quantitative analysis for accurate presentation.
Results and Conclusions:
Poland saw a surge in whooping cough cases post-COVID-19 restrictions, rising from 182 in 2021 to 32,430 in 2024, driven by waning vaccine immunity. Infants face the highest risk, with a mortality rate of up to 1%. Diagnosis relies on PCR, microbiological culture, and serological tests. Macrolides are used for treatment and prophylaxis, reducing transmission if administered early. Acellular vaccines offer effective protection with fewer side effects but require boosters due to shorter immunity duration. Controlling incidence requires maintaining >95% vaccination coverage, targeted antibacterial treatment, and research into new vaccines to address evolving Bordetella pertussis strains.
References
1. Kang HM, Lee TJ, Park SE, Choi SH. Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management. Infect Chemother. 2025 Mar;57(1):13-30. doi: 10.3947/ic.2024.0117. PMID: 40183651; PMCID: PMC11972920.
2. Wawrzyniak A, Moes-Wójtowicz A, Kalicki B, Jung A. Pertussis – disease which cannot be forgotten. Pediatrics and Family Medicine. 2012, 8 (4), p. 335-340. Polish.
3. Rosłonkiewicz-Wiechowska K. Pertussis — an old disease, new methods of prevention. Family Medicine Forum 2017, vol 11, no 3, 107–113.7 ISSN 1897–3590. Polish.
4. Zanetti G, Bakowski E, Hochhegger B, Marchiori E. Pertussis in an adult patient. Rev Soc Bras Med Trop. 2025 Mar 31;58:e009112025. doi: 10.1590/0037-8682-0439-2024. PMID: 40172467; PMCID: PMC11956172.
5. Hua, CZ., He, HQ. & Shu, Q. Resurgence of pertussis: reasons and coping strategies. World J Pediatr 20, 639–642 (2024). https://doi.org/10.1007/s12519-024-00821-2.
6. Locht C. Pertussis before, during and after Covid-19. EMBO Molecular Medicine Volume 17 | April 2025 | 594 – 598. https://doi.org/10.1038/s44321-025-00199-2.
7. See, K.C. Pertussis Vaccination for Adults: An Updated Guide for Clinicians. Vaccines 2025, 13, 60. https://doi.org/10.3390/vaccines13010060.
8. Nitsch-Osuch A. Pertussis in adolescents and adults. Medicine after the Diploma 2010; (19); 10 (175): 93-103.
9. Lauria A.M, Zabbo C.P. Pertussis. StatPearls Publishing; 2025 Jan.
10. Zlamy M. Rediscovering Pertussis. Front Pediatr. 2016 Jun 8;4:52. doi: 10.3389/fped.2016.00052. PMID: 27376050; PMCID: PMC4896922.
11. de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR. Pertussis: a matter of immune modulation. FEMS Microbiol Rev. 2011 May;35(3):441-74. doi: 10.1111/j.1574-6976.2010.00257.x. Epub 2011 Jan 5. PMID: 21204863.
12. Pittet LF, Posfay-Barbe KM. Bordetella holmesii infection: current knowledge and a vision for future research. Expert Rev Anti Infect Ther (2015) 13:965–71. doi:10.1586/14787210.2015.1056161.
13. Fishbain, J. T. et al. Invasive Bordetella holmesii infections. 2014. Infectious Diseases 47(2), pp. 65–68. doi: 10.3109/00365548.2014.968609.
14. Incidence of selected infectious diseases in Poland from January 1 to December 31, 2024 and in the comparable period of 2023.. Polish.
15. Scruggs-Wodkowski E, Malani P. What Is Pertussis? JAMA. 2024;332(12):1030. doi:10.1001/jama.2024.9049.
16. Czarkowski MP, Wielgosz U. Infectious diseases and poisonings in Poland in 2022. Warsaw 2023. ISSN 1643-8655. Polish.
17. Czarkowski MP, Staszewska-Jakubik E, Wielgosz U. Infectious diseases and poisonings in Poland in 2020. Warsaw 2021. ISSN 1643-8655. Polish.
18. Czarkowski MP, Cielebąk E, Kondej B, Sadłocha A. Infectious diseases and poisonings in Poland in 2018. Warsaw 2019. ISSN 1643-8655. Polish.
19. Czarkowski MP, Cielebąk E, Staszewska-Jakubik E, Kondej B. Infectious diseases and poisonings in Poland in 2016. Warsaw 2017. ISSN 1643-8655. Polish.
20. Czarkowski MP, Cielebąk E, Staszewska-Jakubik E, Kondej B. Infectious diseases and poisonings in Poland in 2014. Warsaw 2015. ISSN 1643-8655. Polish.
21. Czarkowski MP, Cielebąk E, Kondej B, Staszewska E. Infectious diseases and poisonings in Poland in 2012. Warsaw 2013. ISSN 1643-8655. Polish.
22. Czarkowski MP, Cielebąk E, Kondej B, Staszewska E. Infectious diseases and poisonings in Poland in 2010. Warsaw 2011. ISSN 1643-8655. Polish.
23. Rumik A, Paradowska-Stankiewicz I. Pertussis in Poland in 2021. Epidemiological Review. 2023;77(3): 372-380. English, Polish. https://doi.org/10.32394/pe.77.33
24. Banasiak B, Zawadzka-Krajewska A. Pertussis – different manifestations and current management recommendations. Pediatrics After the Diploma. 01/ 2017. Polish.
25. Recommended Antimicrobial Agents for Treatment and Postexposure Prophylaxis of Pertussis. Morbidity and Mortality Weekly Report. December 9, 2005 / Vol. 54 / No. RR-14.
26. Winter K, Zipprich J, Harriman K, Murray EL, Gornbein J, Hammer SJ, Yeganeh N, Adachi K, Cherry JD. Risk Factors Associated With Infant Deaths From Pertussis: A Case-Control Study. Clin Infect Dis. 2015 Oct 1;61(7):1099-106. doi: 10.1093/cid/civ472. Epub 2015 Jun 16. PMID: 26082502.
27. Faulkner A. Pertussis in Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Atlanta, GA, 2012
28. Altunaiji SM, et al. Cochrane Review: Antibiotics for whooping cough (pertussis). Evidence-Based Child Health: A Cochrane Review Journal 2012;7(3): 893-956
29. Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD,
30. Patterson L, Correa A, Hall S, Erickson JD. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999;354:2101-5.
31. Krantz I, Norrby SR, Trollfors B. Salbutamol vs. placebo for treatment of pertussis. Pediatr Infect Dis 1985;4:638-40.
32. Peltola H, Michelsson K. Efficacy of salbutamol in treatment of infant pertussis demonstrated by sound spectrum analysis. Lancet 1982;1:310-2.
33. Wang K, Bettiol S, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, Harnden A. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2014;2014:CD003257.
34. Torre D, Tambini R, Ferrario G, Bonetta G. Treatment with steroids in children with pertussis. Pediatr Infect Dis J 1993;12:419-20.
35. Nguyen AW, DiVenere AM, Papin JF, Connelly S, Kaleko M, Maynard JA. Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons. Sci Adv 2020;6:eaay9258.
36. Official Gazette of the Minister of Health Announcement of the Chief Sanitary Inspector of October 31, 2024 on the Immunization Program for the year 2025. Warsaw 2024. Polish.
37. Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S310-S320. doi: 10.1093/infdis/jiaa469. PMID: 34590129; PMCID: PMC8482022.
38. Jia J, Yuan L, Gao W, Yao KH. [Complications of pertussis]. Zhongguo Dang Dai Er Ke Za Zhi. 2019 Jul;21(7):713-717. Chinese. doi: 10.7499/j.issn.1008-8830.2019.07.018. PMID: 31315774; PMCID: PMC7389100.
39. Guo, S., Zhu, Y., Guo, Q., & Wan, C. (2024). Severe pertussis in infants: a scoping review. Annals of Medicine, 56(1). https://doi.org/10.1080/07853890.2024.2352606.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Krzysztof Sajewicz, Julia Dulęba`, Paulina Strzałkowska, Monika Kaźmierczak, Oskar Tudaj, Joanna Koszałko, Aleksandra Mazur, Filip Kin, Julia Kalisiak, Wiktoria Kalas

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 493
Number of citations: 0